Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0000950170-25-090991
Filing Date
2025-06-27
Accepted
2025-06-27 16:59:29
Documents
4

Document Format Files

Seq Description Document Type Size
1 424B5 prosuppjune2025-projatom.htm 424B5 561523
2 GRAPHIC img148425801_0.jpg GRAPHIC 4618
3 GRAPHIC img148425801_1.jpg GRAPHIC 4619
4 GRAPHIC img148425801_2.jpg GRAPHIC 4618
  Complete submission text file 0000950170-25-090991.txt   582278
Mailing Address 22722 29TH DR. SE SUITE 100 SEATTLE WA 98021
Business Address 22722 29TH DR. SE SUITE 100 SEATTLE WA 98021 425-686-1500
ACHIEVE LIFE SCIENCES, INC. (Filer) CIK: 0000949858 (see all company filings)

EIN.: 954343413 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-280585 | Film No.: 251087421
SIC: 2835 In Vitro & In Vivo Diagnostic Substances
(CF Office: 03 Life Sciences)